Reach out to us at The Hetrick Center to ask questions, build a plan, and see whether the supplement-first or supplement-adjunct path makes sense for you
He noted that while the study was relatively short term, the effect was clear and said the once-daily pill could be particularly attractive as an option for people living with diabetes not wanting injectable therapy
Particular focus was on IcoSema, a new drug by Novo Nordisk that combines once-weekly insulin icodec (approved in Europe and other countries, but not yet the U.S.) and semaglutide, a GLP-1 agonist
M.AttiaH
GIP (Glucose-Dependent Insulinotropic Polypeptide) Another incretin hormone that influences insulin secretion and may affect fat metabolism
It boosts collagen and other repair molecules, helps new blood vessels form through VEGF, and lowers scarring by reducing TGF-1 leading to cleaner, faster repair in animal wound models